99% Purity Vorinostat Antineoplastic Vorinostat Powder Pharmaceutical Vorinostat

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung-Vorinostat
• Product Name: Vorinostat
• Name: Vorinostat Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anthelmintics
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 149647-78-9
• Mf: C14h20n2o3
• Melting Point: 161-162
• Density: 1.174
• Refractive Index: 1.566
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 5000/Month

Product Description

99% Purity Vorinostat Antineoplastic Vorinostat Powder Pharmaceutical Vorinostat 

Product Description

Product Details

Product Name	Vorinostat
Appearance	White Powder
CAS No.	149647-78-9
MF	C14H20N2O3

Vorinostat is a group of protein deacetylase (HDAC) inhibitors. It can play a role by inducing cell differentiation, blocking the cell cycle, and inducing cell regulation. Treatment of aggravation, persistence, and recurrence or ineffective cutaneous T-cell lymphoma (CTCL, a non-Hodgkin's lymphoma) after treatment with two systemic drugs. CTCL is a type of T cell carcinoma that affects the white blood cell types of the skin.

Application&Function

Vorinostat can play a role by inducing cell differentiation, blocking the cell cycle, and inducing cell regulation. Treatment of aggravation, persistence, and recurrence or ineffective cutaneous T-cell lymphoma (CTCL, a non-Hodgkin's lymphoma) after treatment with two systemic drugs. CTCL is a type of T cell carcinoma that affects the white blood cell types of the skin.For the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies; treatment of CTCL; treating acute myeloid leukemia.

Specification